Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Feng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4273-6417; OpenAlex author ID A5100381518. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Integrative analysis of pancreatic microbiota and metabolome in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-27942-6↗
  2. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC-1. Last author DOI 10.1002/jbt.22648↗
  3. Synthesis of gold nanoparticles from leaf Panax notoginseng and its anticancer activity in pancreatic cancer PANC-1 cell lines. Last author DOI 10.1080/21691401.2019.1593852↗
  4. Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1). Last author DOI 10.1080/21691401.2019.1594862↗
  5. Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.8b01133↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianwei Xu · 3 shared papers, 2019–2025 · strength 0.48
  2. Lei Wang · 2 shared papers, 2019 · strength 0.24
  3. Yiqing Zhu · 1 shared paper, 2025 · strength 0.24
  4. Xiao Liang · 1 shared paper, 2025 · strength 0.24
  5. Zhen Li · 1 shared paper, 2025 · strength 0.24
  6. Yifan Wang · 1 shared paper, 2025 · strength 0.24
  7. Jian Xu · 1 shared paper, 2021 · strength 0.15
  8. Fataneh Karandish · 1 shared paper, 2018 · strength 0.08
  9. Yongki Choi · 1 shared paper, 2018 · strength 0.08
  10. Sanku Mallik · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.